查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1988269

心理健康篩檢市場：以數位篩檢工具、臨床篩檢工具、紙本工具和穿戴式篩檢工具分類－2026-2032年全球市場預測

Mental Health Screening Market by Digital Screening Tools, Clinical Screening Tools, Paper-Based Tools, Wearable Screening Tools - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，心理健康篩檢市場價值將達到 21.8 億美元，到 2026 年將成長至 23.7 億美元，到 2032 年將達到 39.3 億美元，複合年成長率為 8.75%。

主要市場統計數據
基準年 2025 21.8億美元
預計年份：2026年 23.7億美元
預測年份 2032 39.3億美元
複合年成長率 (%) 8.75%

這是一本權威的心理健康篩檢指南。它揭示了各種篩檢方法、引入這些方法的理由以及塑造現代篩檢實踐的操作重點。

心理健康篩檢在臨床實踐、公共衛生政策和數位創新之間佔據著至關重要的地位。隨著心理健康問題日益普遍的受到各醫療機構的關注，篩檢工具和管道在識別可能需要評估或介入的個體方面發揮關鍵作用。本導言整體情況了該領域，說明了日常使用的工具、分發管道以及實施環境，為讀者在閱讀更詳細的分析章節之前提供一致的指南。

數位創新、嚴格的監管和持續的監測如何融合，將篩檢從一次性測試重新定義為全面的、情境化的照護路徑。

心理健康篩檢領域正經歷著一場變革性的轉變，這主要得益於技術、臨床實踐和人口需求的融合。人工智慧 (AI) 和機器學習正從實驗性的研究對象轉變為篩檢工作流程中的實用組成部分，它們能夠實現更高級的模式識別和自適應評估邏輯，從而提高篩檢的敏感性並減輕受檢者的負擔。同時，以用戶為中心的設計原則和行動優先的開發理念正在提高自助式篩檢工具的使用率和完成率，使其應用範圍超越了傳統的診所環境。

2025 年關稅變化和貿易政策調整為整個篩檢生態系統帶來了供應鏈複雜性的增加，促使過程採取策略性採購、在地化和風險管理措施。

2025年的關稅調整和貿易政策變化為全球心理健康篩檢生態系統中使用的設備和組件供應鏈帶來了營運摩擦。對於生物感測器設備和某些智慧型手錶等硬體依賴產品，進口關稅和海關程序的變化迫使供應商重新評估其策略，製造商和經銷商也被迫考慮替代採購和區域組裝方案。這些營運應對措施正在影響臨床機構和消費管道的採購計劃和庫存管理。

詳細的細分概述，將數位、臨床、紙本和穿戴式篩檢方法與實際實施、檢驗和工作流程影響聯繫起來。

細分分析揭示了不同工具分類如何影響使用者參與流程、臨床工作流程和檢驗要求。基於數位篩檢工具，該領域涵蓋人工智慧工具、行動應用程式和網路平台。人工智慧工具進一步包括機器學習模型和自然語言處理（NLP）聊天機器人，而行動應用程式則分為混合應用程式和原生應用程式。這一數位層需要嚴格的模型可解釋性和持續的效能監控，機器學習流程、互動式代理和應用程式架構之間的差異決定了整合深度、使用者體驗和監管路徑。

美洲、歐洲、中東和非洲以及亞太地區的區域採用促進因素和細微的監管差異，塑造了在地化、檢驗和部署策略。

區域趨勢對推廣路徑、監管和商業化策略有顯著影響。在美洲，成熟的醫療基礎設施、更清晰的數位醫療服務報銷標準以及完善的臨床網路，都為數位篩檢工具快速整合到基層醫療和專科醫生的工作流程中提供了支持。對互通性和大規模試驗計畫的投入，促進了供應商和醫療系統之間的合作，同時，隱私和資料保護標準也在不斷發展，力求在創新與病患權益之間取得平衡。

跨學科技術供應商、設備製造商、臨床研究中心和策略合作夥伴如何塑造檢驗標準、整合路徑和推廣動能。

關鍵企業和機構參與者正在塑造心理健康篩檢領域的創新步伐和標準。專注於人工智慧和行動開發的科技供應商正在加速提升自適應評估、互動式介面和安全數據管道等相關能力。設備製造商正在提高感測器的精度和能效，以支持被動監測；同時，臨床服務機構和學術中心也在不斷累積檢驗和最佳實踐，以促進臨床應用。

領導者應採取切實可行的策略重點，將檢驗的篩檢成果轉化為擴充性、互通性、具有文化適應性的照護路徑，並建立健全的管治。

致力於將篩檢創新轉化為持久影響的產業領導者應優先考慮一系列綜合策略行動。首先，投資嚴格的臨床檢驗和透明的模型管治，以確保工具在不同目標族群中有效發揮作用。這包括前瞻性檢驗研究和減少偏差的考慮。其次，從一開始就將互通性納入設計考量，以實現與電子健康記錄 (EHR) 和護理管理平台的無縫整合，從而將篩檢結果整合到臨床決策和轉診流程中。

結合相關人員訪談、技術評估和文獻整合的嚴謹混合方法研究框架，能夠產生可操作和可複製的見解。

本研究採用混合方法，將與主要相關人員的直接訪談與二手文獻分析相結合，以形成平衡且可操作的觀點。關鍵投入包括對臨床醫生、技術開發人員、設備製造商和採購經理進行結構化訪談，以了解實際操作、挑戰和推廣應用的促進因素。這些定性訪談用於主題分析、最佳實踐識別和推廣應用障礙識別。

一項明確的整合，強調了將創新與檢驗、管治和區域策略相結合的必要性，以將篩檢的進步轉化為切實的臨床效益。

總之，由於數位科技的進步、法規環境的日趨成熟以及臨床工作流程的不斷演進，心理健康篩檢正處於轉折點。該領域正從單一工具轉向一個整合人工智慧評估、行動互動、臨床醫生主導的評估和被動監測的生態系統。雖然這些整合方法有望實現更早的發現和更個人化的護理，但它們也需要嚴格的檢驗、負責任的資料管治和精心設計的實施策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 數位篩檢工具在心理健康篩檢市場的應用

  • 人工智慧驅動的工具
    • 機器學習模型
    • 自然語言處理聊天機器人
  • 行動應用
    • 混合應用
    • 原生應用
  • 網路平台

第9章 臨床篩檢工具在心理健康篩檢市場的應用

  • 臨床醫師訪談
    • 結構化面試
    • 非結構化訪談
  • 自填式問卷
    • 焦慮調查問卷
    • 憂鬱症調查問卷

第10章：印刷媒體工具在心理健康篩檢市場的應用

  • 清單格式
  • 問卷格式

第11章 穿戴式篩檢工具在心理健康篩檢市場的應用

  • 生物感測器設備
  • 智慧型手錶

第12章 心理健康篩檢市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 心理健康篩檢市場：按群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 心理健康篩檢市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國心理健康篩檢市場

第16章：中國心理健康篩檢市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AbleTo, Inc.
  • Happify Health, Inc.
  • Headspace Health, Inc.
  • Lyra Health, Inc.
  • Modern Health, Inc.
  • NeuroFlow Holdings, Inc.
  • Quartet Health, Inc.
  • SilverCloud Health Limited
  • Spring Health, Inc.
  • Talkspace, Inc.
Product Code: MRR-6969F1FC5B3B

The Mental Health Screening Market was valued at USD 2.18 billion in 2025 and is projected to grow to USD 2.37 billion in 2026, with a CAGR of 8.75%, reaching USD 3.93 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.18 billion
Estimated Year [2026] USD 2.37 billion
Forecast Year [2032] USD 3.93 billion
CAGR (%) 8.75%

An authoritative orientation to mental health screening that clarifies modalities, deployment contexts, and the operational priorities shaping modern screening practice

Mental health screening occupies a pivotal place at the intersection of clinical practice, public health policy, and digital innovation. As the prevalence of mental health concerns continues to attract attention across care settings, screening instruments and delivery channels act as the first line of identification for individuals who may require assessment or intervention. This introduction frames the sector by describing the instruments in routine use, the channels that deliver them, and the operational contexts in which they are deployed, offering readers a coherent orientation before deeper analytical sections.

Over recent years, screening modalities have diversified beyond traditional clinician-led assessments to include digital interfaces, wearable biosensors, and hybrid workflows that blend remote and in-person evaluation. These shifts have altered both the patient experience and clinical pathways, embedding screening earlier in care journeys and enabling real-time data capture. Moreover, changes in reimbursement norms and regulatory expectations are shaping how tools are validated and adopted in practice.

This section sets out the foundational terminology and clarifies the distinctions among digital screening tools, clinician-administered instruments, paper-based formats, and wearable technologies. It also highlights the importance of interoperability, data privacy, and user experience, which together determine uptake and utility. By establishing this baseline, the reader gains a structured lens through which subsequent insights and recommendations can be understood and applied.

How digital innovation, regulatory rigor, and continuous monitoring are converging to redefine screening from episodic tests to integrated, context-aware care pathways

The landscape of mental health screening is undergoing transformative shifts driven by convergence of technology, clinical practice, and population-level demand. Artificial intelligence and machine learning have moved from experimental curiosities to pragmatic components of screening workflows, enabling sophisticated pattern recognition and adaptive assessment logic that improves sensitivity and reduces respondent burden. At the same time, user-centric design principles and mobile-first development have improved engagement and completion rates for self-administered tools, broadening reach beyond traditional clinic walls.

Concurrently, regulatory scrutiny and data governance frameworks have intensified, prompting vendors and health systems to prioritize explainability, validation against clinical standards, and secure management of sensitive health information. This has accelerated the adoption of privacy-preserving analytics and federated learning approaches that balance insight generation with patient confidentiality. Interoperability standards and integration with electronic health records have also progressed, allowing screening outputs to flow into clinical workflows and inform care escalation more reliably.

Finally, wearables and biosensor technologies are enabling passive and continuous monitoring paradigms that complement episodic screening, while clinician workflows are adapting to hybrid models that blend digital triage with focused in-person evaluation. Together, these trends signify a structural shift from isolated screening events to continuous, context-aware systems that support early identification and timely intervention.

How 2025 tariff shifts and trade policy adjustments created supply chain complexity and prompted strategic sourcing, localization, and risk management responses across screening ecosystems

Tariff changes and trade policy adjustments in 2025 have introduced operational friction across global supply chains for devices and components used in mental health screening ecosystems. For hardware-dependent products such as biosensor devices and certain smart watches, alterations in import duties and customs procedures have led to recalibrated supplier strategies, prompting manufacturers and distributors to evaluate alternative sourcing and regional assembly options. These operational responses have implications for procurement timelines and inventory management across clinical and consumer-facing channels.

Beyond hardware, shifts in trade policy have affected the distribution of software-enabled devices by altering the economics of cross-border service agreements, licensing arrangements, and the movement of embedded components. Organizations have responded by refining contractual terms, increasing emphasis on localized support capabilities, and exploring regional partnerships to mitigate exposure to tariff volatility. These adaptations have also catalyzed conversations about product modularity and localization of manufacturing processes to preserve supply continuity.

Importantly, stakeholders are prioritizing risk management and scenario planning to minimize service interruptions and maintain compliance with evolving import/export requirements. Health systems and vendors alike are using these policy-induced pressures as a catalyst to streamline procurement practices, diversify supplier bases, and strengthen contractual protections, ensuring continuity of screening services amid an unpredictable trade environment.

A nuanced segmentation overview connecting digital, clinical, paper, and wearable screening modalities to practical implementation, validation, and workflow implications

Segmentation analysis reveals how different tool classes shape user journeys, clinical workflows, and validation needs. Based on Digital Screening Tools, the field includes AI-Powered Tools, Mobile Applications, and Web Platforms; AI-Powered Tools further encompass Machine Learning Models and NLP Chatbots while Mobile Applications divide into Hybrid Apps and Native Apps. This digital tier demands rigorous model explainability and continuous performance monitoring, and the distinctions among machine learning pipelines, conversational agents, and app architectures determine integration depth, user experience, and regulatory pathways.

Based on Clinical Screening Tools, modalities are organized into Clinician Interview and Self-Report Questionnaire; Clinician Interview splits into Structured Interviews and Unstructured Interviews, whereas Self-Report Questionnaire separates into Anxiety Questionnaires and Depression Questionnaires. Structured interviews provide standardized diagnostic scaffolding that supports reproducibility and training, while unstructured interviews retain clinical nuance but require robust clinician training and documentation practices. Self-report instruments focused on anxiety and depression continue to act as frontline indicators, and their psychometric properties and cultural validity remain central to appropriate deployment.

Based on Paper-Based Tools, formats are typically either Checklist Formats or Questionnaire Forms, which continue to play a role in low-resource or face-to-face contexts where digital access is limited. Based on Wearable Screening Tools, the portfolio includes Biosensor Devices and Smart Watches, which enable physiological and behavioral signal capture for passive screening and ongoing monitoring. Across these segmentations, implementation considerations-such as interoperability, clinician acceptance, and validation against clinical outcomes-determine where and how each tool contributes to an effective screening strategy.

Regional adoption drivers and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape localization, validation, and deployment strategies

Regional dynamics materially influence adoption paths, regulation, and commercialization strategies. In the Americas, mature health system infrastructures, greater reimbursement clarity for digital health services, and well-established clinical networks have supported rapid integration of digital screening tools into primary care and specialist workflows. Investment in interoperability and large-scale pilot programs has stimulated collaboration between vendors and health systems, while privacy and data protection standards continue to evolve to balance innovation with patient rights.

In Europe, Middle East & Africa, heterogeneous regulatory environments and varied health system maturity require adaptive strategies. Parts of Europe exhibit comprehensive regulatory frameworks and a strong emphasis on clinical validation and data protection, driving higher expectations for evidence generation. Meanwhile, markets in the Middle East and Africa present both challenges and opportunities: regulatory modernization and targeted public-private partnerships are expanding access, yet infrastructure variability and workforce constraints necessitate solutions tailored to local contexts and resource realities.

In the Asia-Pacific region, rapid digital adoption, high smartphone penetration, and significant investments in telehealth infrastructure create fertile ground for mobile-first screening solutions and scalable digital platforms. Diverse language needs and cultural norms underscore the importance of localized content, culturally validated instruments, and language-specific natural language processing models. Across all regions, aligning product strategies to local regulatory expectations, interoperability standards, and cultural considerations remains essential for sustainable deployment and meaningful clinical impact.

How cross-disciplinary technology vendors, device makers, clinical research centers, and strategic partners are shaping validation standards, integration pathways, and adoption momentum

Key corporate players and institutional contributors shape the innovation cadence and standards within the mental health screening domain. Technology providers specializing in AI and mobile development are accelerating capabilities around adaptive assessment, conversational interfaces, and secure data pipelines. Device manufacturers are refining sensor accuracy and energy efficiency to support passive monitoring, while clinical services and academic centers continue to generate validation evidence and best practices that underpin clinical acceptance.

Collaborations between software vendors and clinical networks are increasingly common, enabling iterative refinement of screening instruments and care pathways. Strategic partnerships with payer organizations and health systems have also evolved to demonstrate clinical utility and operational feasibility in real-world settings. Meanwhile, regulatory specialists and standards bodies are influencing product roadmaps by clarifying evidence expectations, privacy safeguards, and interoperability requirements.

Across the ecosystem, successful organizations exhibit capabilities in cross-disciplinary collaboration, rigorous clinical validation, and scalable technology deployment. They invest in explainable machine learning, robust security engineering, and clinician-facing workflows that reduce administrative burden. By prioritizing these competencies, industry participants position themselves to meet heightened expectations for reliability, accountability, and measurable clinical impact.

Actionable strategic priorities for leaders to move validated screening innovations into scalable, interoperable, and culturally adapted care pathways with robust governance

Industry leaders aiming to translate screening innovations into sustained impact should prioritize an integrated set of strategic actions. First, invest in rigorous clinical validation and transparent model governance to ensure tools perform reliably across diverse populations; this includes prospective validation studies and attention to bias mitigation. Second, design for interoperability from the outset to enable seamless integration with electronic health records and care management platforms, thereby embedding screening outputs into clinical decision-making and referral workflows.

Third, pursue localization and cultural adaptation for content and conversational interfaces to increase engagement and validity in different regions and languages. Fourth, adopt privacy-forward architectures and data minimization strategies that align with evolving regulatory expectations and strengthen user trust. Fifth, diversify supply chains and consider regional manufacturing or assembly options for device-dependent products to reduce exposure to trade disruption and accelerate delivery timelines.

Finally, cultivate partnerships with clinician groups, payers, and public health organizations to establish pragmatic implementation pathways. By combining robust evidence generation, technical interoperability, responsible data practices, and strategic partnerships, organizations can move from promising pilots to scalable, sustainable screening solutions that meaningfully improve pathways to care.

A rigorous mixed-methods research framework combining stakeholder interviews, technical assessment, and literature synthesis to produce actionable and reproducible insights

This research employs a mixed-methods approach that synthesizes primary stakeholder engagement with secondary literature analysis to produce a balanced and actionable perspective. Primary inputs include structured interviews with clinicians, technology developers, device manufacturers, and procurement leaders to capture operational realities, pain points, and adoption drivers. These qualitative engagements inform thematic analysis and the identification of best practices and implementation barriers.

Secondary inputs encompass peer-reviewed literature, regulatory guidance documents, standards publications, and relevant technical specifications to ensure that the analysis reflects current evidence and compliance expectations. Where appropriate, technical evaluations of algorithmic explainability, sensor fidelity, and interoperability protocols have been incorporated to assess maturity and implementation readiness. Triangulation across data sources supports credibility and reduces the risk of single-source bias.

Throughout the methodology, emphasis is placed on transparency, reproducibility, and defensible inference. Limitations are acknowledged, including the evolving nature of regulatory frameworks and the heterogeneity of regional operational contexts, which can affect generalizability. The approach therefore prioritizes actionable insights and strategic implications while noting areas where additional localized investigation is advisable.

A decisive synthesis that highlights the imperative to pair innovation with validation, governance, and regional strategy to translate screening advances into real clinical benefit

In conclusion, mental health screening is at an inflection point driven by digital capabilities, regulatory maturation, and evolving clinical workflows. The field has moved beyond singular instruments toward ecosystems that blend AI-enabled assessments, mobile engagement, clinician-guided evaluation, and passive monitoring. These integrated approaches offer the promise of earlier identification and more personalized pathways to care, but they also require rigorous validation, responsible data governance, and thoughtfully designed implementation strategies.

Stakeholders must therefore balance innovation with accountability by investing in evidence generation, interoperability, and culturally informed design. Supply chain resilience and regional strategy will continue to influence the availability and deployment timelines for device-dependent solutions, while evolving privacy and regulatory expectations will shape product roadmaps and commercialization strategies. By aligning technological capabilities with clinical needs and system constraints, organizations can convert screening advances into sustainable improvements in access and outcomes.

Ultimately, the path forward depends on collaborative ecosystems that prioritize reproducible results, clinician engagement, and patient-centered design, thereby ensuring that screening tools contribute meaningfully to efficient, equitable, and effective mental health care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Mental Health Screening Market, by Digital Screening Tools

  • 8.1. AI-Powered Tools
    • 8.1.1. Machine Learning Models
    • 8.1.2. Nlp Chatbots
  • 8.2. Mobile Applications
    • 8.2.1. Hybrid Apps
    • 8.2.2. Native Apps
  • 8.3. Web Platforms

9. Mental Health Screening Market, by Clinical Screening Tools

  • 9.1. Clinician Interview
    • 9.1.1. Structured Interviews
    • 9.1.2. Unstructured Interviews
  • 9.2. Self-Report Questionnaire
    • 9.2.1. Anxiety Questionnaires
    • 9.2.2. Depression Questionnaires

10. Mental Health Screening Market, by Paper-Based Tools

  • 10.1. Checklist Formats
  • 10.2. Questionnaire Forms

11. Mental Health Screening Market, by Wearable Screening Tools

  • 11.1. Biosensor Devices
  • 11.2. Smart Watches

12. Mental Health Screening Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Mental Health Screening Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Mental Health Screening Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Mental Health Screening Market

16. China Mental Health Screening Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AbleTo, Inc.
  • 17.6. Happify Health, Inc.
  • 17.7. Headspace Health, Inc.
  • 17.8. Lyra Health, Inc.
  • 17.9. Modern Health, Inc.
  • 17.10. NeuroFlow Holdings, Inc.
  • 17.11. Quartet Health, Inc.
  • 17.12. SilverCloud Health Limited
  • 17.13. Spring Health, Inc.
  • 17.14. Talkspace, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MENTAL HEALTH SCREENING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MENTAL HEALTH SCREENING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MACHINE LEARNING MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MACHINE LEARNING MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MACHINE LEARNING MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NLP CHATBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NLP CHATBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NLP CHATBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY HYBRID APPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY HYBRID APPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY HYBRID APPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NATIVE APPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NATIVE APPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY NATIVE APPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY WEB PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY WEB PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY WEB PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY STRUCTURED INTERVIEWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY STRUCTURED INTERVIEWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY STRUCTURED INTERVIEWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY UNSTRUCTURED INTERVIEWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY UNSTRUCTURED INTERVIEWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY UNSTRUCTURED INTERVIEWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY ANXIETY QUESTIONNAIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY ANXIETY QUESTIONNAIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY ANXIETY QUESTIONNAIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY DEPRESSION QUESTIONNAIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY DEPRESSION QUESTIONNAIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY DEPRESSION QUESTIONNAIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CHECKLIST FORMATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CHECKLIST FORMATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY CHECKLIST FORMATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY QUESTIONNAIRE FORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY QUESTIONNAIRE FORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY QUESTIONNAIRE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY BIOSENSOR DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY BIOSENSOR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY BIOSENSOR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SMART WATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SMART WATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY SMART WATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 146. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 147. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 148. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 149. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 150. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 152. GCC MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 171. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 173. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 174. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 175. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 176. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 177. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 179. G7 MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 180. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 182. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 183. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 184. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 185. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 186. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 187. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 188. NATO MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL MENTAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA MENTAL HEALTH SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY DIGITAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY AI-POWERED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICAL SCREENING TOOLS, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY CLINICIAN INTERVIEW, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY SELF-REPORT QUESTIONNAIRE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY PAPER-BASED TOOLS, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA MENTAL HEALTH SCREENING MARKET SIZE, BY WEARABLE SCREENING TOOLS, 2018-2032 (USD MILLION)